Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?news2024-06-17T21:59:44+00:00June 17th, 2024|The New York Times|
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefitsnews2024-06-10T09:00:35+00:00June 10th, 2024|The New York Times|
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’snews2024-05-06T16:19:15+00:00May 6th, 2024|The New York Times|
F.D.A. Delays Action on Closely Watched Alzheimer’s Drugnews2024-03-08T11:45:07+00:00March 8th, 2024|The New York Times|
¿Se puede tener alzhéimer y no presentar síntomas?news2024-03-06T15:35:15+00:00March 6th, 2024|The New York Times|
Apparently Healthy, but Diagnosed With Alzheimer’s?news2024-03-04T17:25:50+00:00March 4th, 2024|The New York Times|
Trump’s Takeover of the Republican Partynews2024-02-15T17:38:23+00:00February 15th, 2024|The New York Times|
What to Know About Mild Cognitive Impairment Treatmentnews2024-02-06T17:44:41+00:00February 6th, 2024|The New York Times|
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelmnews2024-01-31T19:10:58+00:00January 31st, 2024|The New York Times|
